Difference between revisions of "ENDO5:Volunteer Assignments and Opportunities"
Jump to navigation
Jump to search
[checked revision] | [checked revision] |
(4 intermediate revisions by the same user not shown) | |||
Line 16: | Line 16: | ||
!'''Date of Last Editor Review''' | !'''Date of Last Editor Review''' | ||
!'''Notes''' | !'''Notes''' | ||
+ | |- | ||
+ | |CHAPTER 2 (PITUITARY TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[ENDO5:Somatotroph_PitNET/adenoma|Somatotroph PitNET/adenoma]] | |[[ENDO5:Somatotroph_PitNET/adenoma|Somatotroph PitNET/adenoma]] | ||
Line 258: | Line 278: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 3 (THYROID TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[ENDO5:Thyroglossal_duct_cyst|Thyroglossal duct cyst]] | |[[ENDO5:Thyroglossal_duct_cyst|Thyroglossal duct cyst]] | ||
Line 533: | Line 573: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 4 (PARATHYROID TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[ENDO5:Parathyroid_hyperplasia|Parathyroid hyperplasia]] | |[[ENDO5:Parathyroid_hyperplasia|Parathyroid hyperplasia]] | ||
Line 588: | Line 648: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 5 (ADRENAL GLAND TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[ENDO5:Adrenal_rests|Adrenal rests]] | |[[ENDO5:Adrenal_rests|Adrenal rests]] | ||
Line 698: | Line 778: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 6 (ADRENAL MEDULLA AND EXTRA-ADRENAL PARAGANGLIA TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[ENDO5:Neuroblastoma|Neuroblastoma]] | |[[ENDO5:Neuroblastoma|Neuroblastoma]] | ||
Line 786: | Line 886: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 7 (PANCREATIC NEUROENDOCRINE NEOPLASMS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[ENDO5:Non-functioning_(non-syndromic)_pancreatic_neuroendocrine_tumours|Non-functioning (non-syndromic) pancreatic neuroendocrine tumours]] | |[[ENDO5:Non-functioning_(non-syndromic)_pancreatic_neuroendocrine_tumours|Non-functioning (non-syndromic) pancreatic neuroendocrine tumours]] | ||
Line 907: | Line 1,027: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 8 (NEUROENDOCRINE NEOPLASMS IN NON-ENDOCRINE ORGANS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[ENDO5:Neuroendocrine_tumours|Neuroendocrine tumours]] | |[[ENDO5:Neuroendocrine_tumours|Neuroendocrine tumours]] | ||
Line 984: | Line 1,124: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 9 (MESENCHYMAL AND STROMAL TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[ENDO5:Lipoma|Lipoma]] | |[[ENDO5:Lipoma|Lipoma]] | ||
Line 1,127: | Line 1,287: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |CHAPTER 10 (HAEMATOLYMPHOID TUMOURS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
|- | |- | ||
|[[ENDO5:IgG4-related_disease|IgG4-related disease]] | |[[ENDO5:IgG4-related_disease|IgG4-related disease]] | ||
Line 1,205: | Line 1,385: | ||
| | | | ||
|- | |- | ||
− | | | + | |CHAPTER 11 (GERM CELL TUMOURS) |
− | + | | | |
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
|- | |- | ||
− | |[[ENDO5: | + | |[[ENDO5:Germ_cell_tumours_in_endocrine_organs|Germ cell tumours in endocrine organs]] |
|Disease | |Disease | ||
| | | | ||
Line 1,227: | Line 1,416: | ||
| | | | ||
|- | |- | ||
− | |[[ENDO5: | + | |[[ENDO5:Teratomas_with_endocrine_differentiation|Teratomas with endocrine differentiation]] |
|Disease | |Disease | ||
| | | | ||
Line 1,238: | Line 1,427: | ||
| | | | ||
|- | |- | ||
− | | | + | |CHAPTER 12 (METASTASIS) |
− | + | | | |
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
|- | |- | ||
− | |[[ENDO5: | + | |[[ENDO5:Metastasis_to_the_pituitary_gland|Metastasis to the pituitary gland]] |
|Disease | |Disease | ||
| | | | ||
Line 1,260: | Line 1,458: | ||
| | | | ||
|- | |- | ||
− | |[[ENDO5: | + | |[[ENDO5:Metastasis_to_the_thyroid_gland|Metastasis to the thyroid gland]] |
|Disease | |Disease | ||
| | | | ||
Line 1,271: | Line 1,469: | ||
| | | | ||
|- | |- | ||
− | |[[ENDO5: | + | |[[ENDO5:Metastasis_to_the_adrenal_gland|Metastasis to the adrenal gland]] |
|Disease | |Disease | ||
| | | | ||
Line 1,282: | Line 1,480: | ||
| | | | ||
|- | |- | ||
− | | | + | |CHAPTER 13 (GENETIC TUMOUR SYNDROMES ASSOCIATED WITH ENDOCRINE LESIONS AND TUMOURS) |
− | + | | | |
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
+ | |- | ||
+ | |[[ENDO5:Multiple_endocrine_neoplasia_type_1|Multiple endocrine neoplasia type 1]] | ||
+ | |Disease | ||
+ | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
|- | |- | ||
− | |[[ENDO5: | + | |[[ENDO5:Multiple_endocrine_neoplasia_type_2|Multiple endocrine neoplasia type 2]] |
+ | |Disease | ||
+ | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |- | ||
+ | |[[ENDO5:Multiple_endocrine_neoplasia_type_4|Multiple endocrine neoplasia type 4]] | ||
|Disease | |Disease | ||
| | | | ||
Line 1,304: | Line 1,533: | ||
| | | | ||
|- | |- | ||
− | |[[ENDO5: | + | |[[ENDO5:Multiple_endocrine_neoplasia_type_5_(MAX-related_tumours)|Multiple endocrine neoplasia type 5 (MAX-related tumours)]] |
|Disease | |Disease | ||
| | | | ||
Line 1,315: | Line 1,544: | ||
| | | | ||
|- | |- | ||
− | |[[ENDO5: | + | |[[ENDO5:Hyperparathyroidism-jaw_tumour_syndrome|Hyperparathyroidism-jaw tumour syndrome]] |
|Disease | |Disease | ||
| | | | ||
Line 1,325: | Line 1,554: | ||
| | | | ||
| | | | ||
+ | |- | ||
+ | |[[ENDO5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]] | ||
+ | |Disease | ||
+ | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
|- | |- | ||
|[[ENDO5:SDH-deficient_tumour_syndromes|SDH-deficient tumour syndromes]] | |[[ENDO5:SDH-deficient_tumour_syndromes|SDH-deficient tumour syndromes]] | ||
|Disease | |Disease | ||
− | | | + | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[ENDO5:Neurofibromatosis_type_1|Neurofibromatosis type 1]] | |[[ENDO5:Neurofibromatosis_type_1|Neurofibromatosis type 1]] | ||
|Disease | |Disease | ||
− | | | + | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[ENDO5:Carney_complex|Carney complex]] | |[[ENDO5:Carney_complex|Carney complex]] | ||
Line 1,372: | Line 1,612: | ||
|[[ENDO5:DICER1_syndrome|DICER1 syndrome]] | |[[ENDO5:DICER1_syndrome|DICER1 syndrome]] | ||
|Disease | |Disease | ||
− | | | + | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
− | | | + | |N/A |
|- | |- | ||
|[[ENDO5:Glucagon_cell_hyperplasia_and_neoplasia|Glucagon cell hyperplasia and neoplasia]] | |[[ENDO5:Glucagon_cell_hyperplasia_and_neoplasia|Glucagon cell hyperplasia and neoplasia]] |
Revision as of 16:40, 15 July 2024
Welcome!
For assignments, please see the "Author" column below (highlighted blue).
If empty (no name is present), please volunteer to create content for that disease!
To volunteer, please [Contact us] with your page of interest.